Latest Market Risks News

Tungsten Mining has completed a $53 million placement, oversubscribed by institutional investors, positioning the company to accelerate development of its key tungsten projects. The funds will support exploration and feasibility studies with results expected later this year.

CAR Group has reported strong first-half results for FY26, with double-digit revenue and earnings growth across all key regions, underpinned by strategic AI investments and expanding market presence.

WAM Active Limited has launched a $51.4 million pro-rata entitlement offer at a 7.8% discount to the recent share price, alongside a $19.3 million institutional placement to meet strong investor demand. The capital raising aims to bolster the company’s proven Australian equity investment strategy while offering shareholders fully franked dividends on new shares.

New Age Exploration Limited has issued a prospectus to facilitate secondary trading of new options issued under a recent $3.75 million placement, offering 1,000 new options at $0.01 each. The move aims to remove trading restrictions and improve liquidity for option holders.

Lotus Resources has launched a A$76 million placement alongside a A$5 million share purchase plan to fund the ramp-up of uranium production at its Kayelekera mine, aiming for steady-state output by mid-2026 amid strong market fundamentals.

360 Capital Mortgage REIT reported a robust half-year performance with a 40.5% increase in gross assets and a targeted 10.4% distribution yield for FY26, underpinned by disciplined lending and solid capital raising.

Tungsten Mining NL has launched a Project Economic Evaluation to explore accelerated development of its Watershed Project, leveraging existing approvals to potentially fast-track production in a tightening tungsten market.

Altamin Limited progresses its Lazio geothermal lithium and SOP project with key technical studies and grant funding, while advancing a strategic sale process for its Gorno polymetallic project. The company bolsters its balance sheet through a successful entitlement offer raising A$5.39 million.

Australian Rare Earths Limited (ASX – AR3) has made significant strides in advancing its Koppamurra Rare Earths Project, securing pilot-scale processing at ANSTO’s new facility and raising $6 million post-quarter to fund development. Concurrently, promising uranium targets have been identified at its Overland Project.

Stavely Minerals is advancing its 2026 Scoping Study for the Stavely Copper-Gold Project, targeting a significant production scale boosted by strong copper, gold, and silver prices. The company aims to outline a pathway to over 10 years of mine life with a mid-year study delivery.

PainChek has achieved FDA regulatory clearance enabling its device to qualify for US Remote Therapeutic Monitoring reimbursement, positioning the company for significant growth in the expanding US healthcare market. The company also reports strong global licence growth and a solid pipeline across multiple regions.

PainChek has secured FDA De Novo clearance, enabling entry into the vast US healthcare market with a $3 billion Remote Therapeutic Monitoring opportunity. The company reports $5.6 million contracted ARR and a strong global footprint in aged care.